Chemotherapy Induced Peripheral Neuropathy Treatment - PowerPoint PPT Presentation

About This Presentation
Title:

Chemotherapy Induced Peripheral Neuropathy Treatment

Description:

The chemotherapy induced peripheral neuropathy treatment market size is expected to see strong growth in the next few years. It will grow to $2.25 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. – PowerPoint PPT presentation

Number of Views:0
Date added: 25 April 2024
Slides: 9
Provided by: ramtbrc
Tags:

less

Transcript and Presenter's Notes

Title: Chemotherapy Induced Peripheral Neuropathy Treatment


1
Chemotherapy Induced Peripheral Neuropathy
Treatment
Global Market Report 2024
Global Forecast 2024 2033 Market Size, Drivers,
And Trends Top Market Research Firm 2023! We
are honored to be listed as a top company at the
forefront of research, by the Business
Management Review
2
Chemotherapy Induced Peripheral Neuropathy
Treatment Market Segments
The Business Research Company segments the
chemotherapy induced peripheral neuropathy
treatment market report a
Nerve Protective Therapy, Anti-Inflammatory
Therapy, Neurotransmitter Based Therapy,
Antioxidant, Other Drug Classes
ByByTeScohunrocelogy
Medication, Therapy, Other Treatments
ByBTyreFaotrment
Branded, Generic
BByyADprpulgicaTtyipoen
Hospital Pharmacy, Retail Pharmacy, Online
Pharmacies, Other Distribution Channels
By Distr.ibution
.
Hospitals, Research Institutes, Specialty Clinics
By End-User
.
.
3
Market Statistics
The chemotherapy induced peripheral neuropathy
  • treatment market size has grown strongly in
    recent years. It will grow from 1.54 billion in
    2023 to 1.65 billion in 2024 at a compound
    annual growth rate (CAGR) of 7.5. The
    chemotherapy induced peripheral neuropathy
    treatment market size is expected to see strong
    growth in the next few years. It will grow to
    2.25 billion in 2028 at a compound annual
    growth rate (CAGR) of 8.0.

2.25 B
1.65 B
1.54 B
Click Here To Get A Sample Report
4
Key Market Drivers And Trends
Drivers The increasing prevalence of cancer is
expected to propel the growth of the
chemotherapy-induced peripheral neuropathy
treatment market going forward. Trends Product
Innovation is the key trend gaining popularity in
the chemotherapy-induced peripheral neuropathy
treatment market. Region North America was the
largest region in the chemotherapy induced
peripheral neuropathy treatment market in 2023.
Asia-Pacific and Europe are expected to be the
fastest-growing regions in the forecast period.
The regions covered in the chemotherapy induced
peripheral neuropathy treatment market report
are Asia-Pacific, Western Europe, Eastern Europe,
North America, South America, Middle
East, Africa.
5
Top Players In The Market
Major companies operating in the chemotherapy
induced peripheral neuropathy treatment market
report are Sanofi SA, Bristol Myers Squibb,
Abbott Laboratories, Takeda Pharmaceutical
Company, Amgen Inc., Asahi Kasei Pharma
Corporation, Toray Industries , Vertex
Pharmaceuticals Inc., Alexion Pharmaceuticals
Inc., BioMérieux SA, Jazz Pharmaceuticals Inc.,
WEX Pharmaceuticals Inc., Quidel Corporation,
Laboratories Dr. Esteve S.A. (ESTEVE), Genentech
Inc., MediciNova Inc., ChromaDex Corp, WinSanTor
Inc., Solasia Pharma K.K., NeuroMetrix Inc.,
Nemus Bioscience Inc., Aphios Corporation, Kineta
Inc., DARA BioSciences Inc., Aptinyx Inc.,
Apexian Pharmaceuticals Inc., Krenitsky
Pharmaceuticals Inc.
Get More Information On The Market Report
6
7 Reasons Why TBRC Is The Solution You Need
  1. Global Macroeconomic Impact Assess global
    economic factors' influence on market growth.
  2. Market Size Ratios Explore market size, GDP
    proportions, and expenditure per capita.
  3. Global Perspective Reports cover 60 geographies
    for a comprehensive global understanding.
  4. Localized Strategies Create region-specific
    strategies aligning with market nuances.
  5. Investment Insights Identify growth segments
    through forecast data and market insights.
  6. Competitor Benchmarking Compare performance
    against key competitors.
  7. Presentation Support Reports offer reliable data
    for internal and external presentations.

7
Americas The Business Research Company, 1295 N
Providence Rd, Oxygen, PA 19063, USA ? 1
3156230293
Get In Touch How ever you want to grow and
expand, The Business Research Company can help
as we provide research consulting solutions for
businesses, government agencies consultancies,
and market research companies.
Europe The Business Research Company 47
Anchorage Point, 42 Cuba Street, Canary Wharf,
London, England, E14 8NE
? 44 207 1930 708
Asia The Business Research Company, 1st Floor,
Anshu Colors Building, Road Number 1, Park View
Enclave, Jubilee Hills, Hyderabad (India), 500033
info_at_tbrc.info
? 91 8897263534
_at_The Business Research Company. All rights
reserved.
rch Company. All Rights Reserved.
The Business Resea
8
Your Growth Insights Partner
The Business Research Company. All Rights
Reserved.
Write a Comment
User Comments (0)
About PowerShow.com